Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning

Medical Dosimetry

Volumn 38, Issue 3, 2013, Pages 298-303

  Wala, Jeremiah ^a,b   Craft, David ^a,b   Paly, Jon ^b   Zietman, Anthony ^a,b   Efstathiou, Jason ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

IMRT; Multicriteria optimization; Prostate

Indexed keywords

ARTICLE; BLADDER; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER INTERFACE; COMPUTER SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; FEMUR HEAD; HEALTH CARE QUALITY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MAXIMUM PERMISSIBLE DOSE; MULTICRITERIA OPTIMIZATION PLANNING SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RADIATION DOSE; RECTUM; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

IMRT; MULTICRITERIA OPTIMIZATION; PROSTATE;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84881117941     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2013.02.012     Document Type: Article

References (26)

1. Bekelman J.E., Mitra N., Efstathiou J., et al. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81:e325-e334.
2. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J. Urol. 2001, 166:876-881.
3. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1124-1129.
4. Cotrutz C., Lahanas M., Kappas C., et al. A multiobjective gradient based dose optimization algorithm for external beam conformal radiotherapy. Phys. Med. Biol. 2001, 46:2161-2175.
5. Craft D.L., Halabi T.F., Shih H.A., et al. Approximating convex Pareto surfaces in multiobjective radiotherapy planning. Med. Phys. 2006, 33:3399-3407.
6. Craft D.L., Halabi T.F., Shih H.A., et al. An approach for practical multiobjective IMRT treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:1600-1607.
7. Das S. A method to dynamically balance intensity modulated radiotherapy dose between organs-at-risk. Med. Phys. 2011, 38:2964-2974.
8. Holdsworth C., Kim M., Liao J., et al. A hierarchial evolutionary algorithm for multiobjective optimization in IMRT. Med. Phys. 2010, 37:4986-4997.
9. Holdsworth C., Stewart R.D., Kim M., et al. Investigation of effective decision criteria for multiobjective optimization in IMRT. Med. Phys. 2011, 38:2964-2974.
10. Lahanas M., Schreibmann E., Baltas D. Multiobjective inverse planning for intensity modulated radiotherapy with contraint-free gradient-based optimization algorithms. Phys. Med. Biol. 2003, 48:2843-2871.
11. Pardo-Montero J., Fenwick J. An approach to multiobjective optimization of rotational therapy. II. Pareto optimal surfaces and linear combinations of modulated blocked arcs for prostate geometry. Med. Phys. 2010, 37:2606-2616.
12. Thieke C., Küfer K.H., Monz M., et al. A new concept for interactive radiotherapy planning with multicriteria optimization: First clinical evaluation. Radiother. Oncol. 2007, 85:292-298.
13. Hong T.S., Craft D.L., Carlsson F., et al. Multicriteria optimization in IMRT treatment planning for locally advanced cancer of the pancreatic head. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:1208-1214.
14. Spalke T., Craft D., Bortfeld T. Analyzing the main trade-offs in multiobjective radiation therapy treatment planning databases. Phys. Med. Biol. 2009, 54:3741-3754.
15. Craft D., Hong T., Shih H., et al. Improving planning time and plan quality through multicriteria optimization for intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2012, 82:e83-e90.
16. Marks L.B., Yorke E.D., Jackson A., et al. Use of normal tissue complication probability models in the clinic. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:S10-S19.
17. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med. Phys. 1997, 24:103-110.
18. Craft D., Bortfeld T. How many plans are needed in an IMRT multi-objective plan database?. Phys. Med. Biol. 2008, 53:2785-2796.
19. Al-Mamgani A., Heemsbergen W.D., Peeters S.T., et al. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2009, 73:685-691.
20. Beckendorf V., Guerif S., Le Prisé E., et al. 70Gy versus 80Gy in localized prostate cancer: 5-Year results of GETUG 06 randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2011, 80:1056-1063.
21. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br. J. Cancer 2005, 92:488-498.
22. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53:1097-1105.
23. Zietman A.L., Bae K., Slater J.D., et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from proton radiation oncology group/american college of radiology. J. Clin. Oncol. 2010, 28:1106-1111.
24. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. J. Am. Med. Assoc. 2005, 294:1233-1239.
25. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:67-74.
26. Kuban D., Pollack A., Huang E., et al. Hazards of dose escalation in prostate cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57:1260-1268.